Albuterol information from trusted sources:
The active component of Albuterol Inhalation Aerosol is albuterol, USP, racemic α1-[(tert-butylamino)methyl]-4-hydroxy-m-xylene-α,α'-diol) and a relatively selective beta2-adrenergic bronchodilator having the following structural formula:Albuterol is the official generic name in the United States. The World Health Organization recommended name for the drug is salbutamol. The molecular weight of albuterol is 239.32, and the molecular formula is C13H21NO3. Albuterol is a white to off-white crystalline solid. It is soluble in ethanol, sparingly soluble in water, and very soluble in chloroform. Albuterol Inhalation Aerosol is indicated for the prevention and relief of bronchospasm in patients 4 years of age and older with reversible obstructive airway disease and for the prevention of exercise-induced bronchospasm in patients 4 years of age and older.
Albuterol tablets contain albuterol sulfate, USP, the racemic form of albuterol and a relatively selective beta2-adrenergic bronchodilator.
Albuterol is used to prevent and treat wheezing, difficulty breathing and chest tightness caused by lung diseases such as asthma and chronic obstructive pulmonary disease (COPD, a group of diseases that affect the lungs and airways). Albuterol is in a class of medications called bronchodilators. It works by relaxing and opening the air passages to the lungs to make breathing easier.
Levalbuterol belongs to the family of adrenergic bronchodilators. Levalbuterol is used to prevent or treat chest tightness, shortness of breath, troubled breathing and wheezing associated with bronchospasm.
Xopenex is a bronchodilator. It works by relaxing the muscles in the walls of the lungs' many tiny airways (bronchioles), allowing them to expand so you can get more air. It is prescribed for asthma.
The active ingredient of Albuterol Sulfate HFA Inhalation Aerosol is albuterol sulfate, a racemic salt, which is a relatively selective beta2-adrenergic bronchodilator. Albuterol sulfate has the chemical name α1-[(tert -butylamino) methyl]-4-hydroxy- m -xylene-α,α'-diol sulfate (2:1) (salt), and has the following chemical structure: The molecular weight of albuterol sulfate is 576.7, and the empirical formula is (C13H21NO3)2•H2SO4. Albuterol sulfate is a white to off-white...
Beta-adrenergic-receptor blocking agents not only block the pulmonary effect of beta-agonists, such as Albuterol Sulfate HFA Inhalation Aerosol, but may produce severe bronchospasm in asthmatic patients. Therefore, patients with asthma should not normally be treated with beta-blockers. However, under certain circumstances, e.g., as prophylaxis after myocardial infarction, there may be no acceptable alternatives to the use of beta-adrenergic-blocking agents in patients with asthma. In this setting,...
A total of 973subjects were treated with Albuterol Sulfate HFA Inhalation Aerosol during the worldwide clinical development program.
Albuterol Sulfate HFA Inhalation Aerosol is indicated in adults and children 12 years of age and older for the treatment or prevention of bronchospasm with reversible obstructive airway disease.
Ipratropium and Albuterol Inhalation
The combination of ipratropium and albuterol is used to prevent wheezing, difficulty breathing, chest tightness, and coughing in people with chronic obstructive pulmonary disease (COPD, a group of diseases that affect the lungs and airways) such as chronic bronchitis (swelling of the air passages that lead to the lungs) and emphysema (damage to the air sacs in the lungs). Ipratropium and albuterol combination is used by people whose symptoms have not been controlled by a single inhaled medication. Ipratropium and albuterol are in a class of medications called bronchodilators. Ipratropium and albuterol combination works by relaxing and opening the air passages to the lungs to make breathing easier.